RUNX2
RUNX2, also known as Runt-related transcription factor 2, is a protein that in humans is encoded by the RUNX2 gene. This protein plays a critical role in the differentiation of osteoblasts, cells that are responsible for bone formation. Due to its pivotal role in skeletal development, mutations in RUNX2 are associated with a variety of bone-related disorders.
Function[edit]
RUNX2 is a key transcription factor in osteoblast differentiation and skeletal morphogenesis. It is essential for the maturation of osteoblasts and is involved in the expression of several genes related to bone formation, including osteocalcin, bone sialoprotein, and osteopontin. RUNX2 functions by binding to specific DNA sequences, thereby regulating the activity of genes important for bone development and maintenance.
Genetic Structure[edit]
The RUNX2 gene is located on the human chromosome 6p21. It consists of multiple exons that encode the RUNX2 protein. This protein contains a Runt domain, which is involved in DNA binding and protein-protein interactions, crucial for its function as a transcription factor.
Clinical Significance[edit]
Mutations in the RUNX2 gene can lead to skeletal disorders. The most well-known condition associated with RUNX2 mutations is Cleidocranial Dysplasia (CCD), a rare genetic disorder characterized by delayed closure of cranial sutures, abnormal development of clavicles, and dental anomalies. Patients with CCD exhibit a wide range of skeletal abnormalities, underscoring the importance of RUNX2 in bone development and maintenance.
Research and Applications[edit]
Research on RUNX2 has expanded our understanding of bone biology and the molecular mechanisms underlying bone diseases. This knowledge has potential applications in developing therapeutic strategies for bone-related conditions. For instance, manipulating RUNX2 activity could offer new approaches to enhancing bone regeneration and treating osteoporosis.
See Also[edit]
References[edit]
<references />
RUNX2[edit]
-
Oscillations of Runx2 mRNA levels
-
Schematic of Runx2 Levels During Cell Cycle Progression
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
